What is Adaptive DBS?
Adaptive Deep Brain Stimulation (aDBS) represents a cutting-edge evolution in neuromodulation therapy, particularly for Parkinson’s disease and other movement disorders. Unlike traditional DBS, aDBS operates as a “closed-loop” system that dynamically responds to a patient’s brain activity in real time.
Core Components
aDBS relies on three main elements: sensing electrodes implanted in brain targets like the subthalamic nucleus, an implantable pulse generator (IPG) with sensing capabilities (e.g., Medtronic’s Percept series with BrainSense technology), and sophisticated algorithms. The electrodes both deliver electrical pulses and record local field potentials (LFPs)—low-frequency electrical signals reflecting synchronized neuronal activity. These LFPs capture pathological oscillations, especially elevated beta-band activity (13-30 Hz), which correlates strongly with motor symptoms like bradykinesia and rigidity.
- Signal Detection: The system continuously monitors LFPs from the stimulation site, detecting biomarker spikes indicating symptom worsening (e.g., high beta power during “off” medication states).
- Algorithm Processing: A patient-specific algorithm compares real-time signals against personalized thresholds set during programming visits. If beta activity exceeds limits, it signals the need for intervention; stable activity triggers reduction.
- Dynamic Adjustment: Stimulation amplitude ramps up (e.g., from 1-5 mA) within milliseconds to suppress abnormal oscillations, mimicking neural jamming or inhibition without constant high output. When symptoms stabilize, it downscales to minimize side effects like dysarthria or energy drain.
- Feedback Loop: Adjustments occur every few seconds, adapting to daily fluctuations from medications, stress, or disease progression—far faster than manual clinician tweaks.
Advantages Over Standard DBS
Standard DBS uses fixed, open-loop stimulation, over-treating stable periods and under-treating peaks, which can waste battery and cause side effects. In contrast, aDBS cuts energy use by 40-50% while improving motor scores by up to 60%, as shown in trials like ADAPT-PD. At centers like Manipal Hospital Sarjapur Road’s DBS Clinic, this enables precise, personalized care building on established DBS expertise.
How does adaptive DBS help patients with Parkinson’s Disease?
- Adaptive DBS appears at least as effective as traditional DBS for medication reduction, and in selected patients may allow greater tapering of dopaminergic drugs.
- aDBS therapy consistently show similar or better motor benefit than cDBS with ~48–74% less stimulation energy.
- In aDBS patients had better “on” time and chose to remain on aDBS, suggesting it manages fluctuations well enough to support bolder medication reductions.
Adaptive DBS (adBS) offers comparable or better symptom control with less stimulation and may, in selected individuals, allow more aggressive medication reduction—even complete withdrawal in rare cases—while aiming to reduce dyskinesia and other side‑effects